# Pure Pathological Gait Detection - Final Report

**Date**: 2025-10-30
**Task**: ì˜ì¡± ë³´í–‰ ì œì™¸ í›„ ìˆœìˆ˜ ë³‘ì  ë³´í–‰ ê²€ì¶œ ì¬í‰ê°€
**Status**: âœ… COMPLETE

---

## Executive Summary

ì˜ì¡±(prosthetic)ê³¼ ìš´ë™(exercise)ì„ ì œì™¸í•œ **ìˆœìˆ˜ ë³‘ì  ë³´í–‰**ë§Œìœ¼ë¡œ ì¬í‰ê°€í•œ ê²°ê³¼:

### ğŸ¯ Key Finding

**ì„±ëŠ¥ì´ ê±°ì˜ ê°œì„ ë˜ì§€ ì•ŠìŒ**: 51.6% â†’ **57.0%** (+5.4%)

**í•µì‹¬ ë¬¸ì œ**: ëŒ€ë¶€ë¶„ì˜ ë³‘ì  ë³´í–‰ì´ ì •ìƒ ë³´í–‰ê³¼ **íŠ¹ì§•ì´ ê±°ì˜ ë™ì¼**í•¨

---

## 1. ë°ì´í„° ì¬êµ¬ì„±

### 1.1 ì œì™¸ í•­ëª©

**Prosthetic (ì˜ì¡±)**: 5ê°œ
- ì´ìœ : ê¸°ê³„ì  ë³´í–‰, ì§ˆë³‘ ì•„ë‹˜
- íŠ¹ì§•: ëª…í™•í•œ ë¹„ëŒ€ì¹­ì„± (1.34 vs 0.50)

**Exercise (ìš´ë™)**: 28ê°œ
- ì´ìœ : ì •ìƒ ë³€í˜•, ë³‘ë¦¬ ì•„ë‹˜
- íŠ¹ì§•: ë¹ ë¥¸ ë³´í–‰, ë†’ì€ ì§„í­

### 1.2 ìˆœìˆ˜ ë³‘ì  ë³´í–‰

**í¬í•¨ëœ í´ë˜ìŠ¤** (ì´ 91ê°œ):
```
abnormal: 73ê°œ (ì¼ë°˜ ë¹„ì •ìƒ)
cerebral palsy: 8ê°œ (ë‡Œì„±ë§ˆë¹„)
stroke: 7ê°œ (ë‡Œì¡¸ì¤‘)
antalgic: 2ê°œ (í†µì¦ì„± ë³´í–‰)
inebriated: 1ê°œ (ì·¨í•œ ìƒíƒœ)
```

**ëŒ€ì¡°êµ°**:
```
normal: 98ê°œ
```

---

## 2. í‰ê°€ ê²°ê³¼

### 2.1 ì „ì²´ ì„±ëŠ¥

| Method | Accuracy | Sensitivity | Specificity |
|--------|----------|-------------|-------------|
| DTW | 52.7% | 56.8% | 49.0% |
| **Scalar** | **57.0%** | 40.9% | 71.4% |
| Hybrid (0.3) | 55.4% | 37.5% | 71.4% |
| Hybrid (0.5) | 56.5% | 40.9% | 70.4% |
| Hybrid (0.7) | 56.5% | 44.3% | 67.3% |

**Best: Scalar (57.0% accuracy)**

### 2.2 ì„±ëŠ¥ ë¹„êµ

| ì¡°ê±´ | Accuracy | ê°œì„  |
|------|----------|------|
| ì›ë³¸ (prosthetic í¬í•¨) | 51.6% | baseline |
| **ìˆœìˆ˜ ë³‘ì  (ì œì™¸)** | **57.0%** | **+5.4%** |

**ê²°ë¡ **: ì˜ì¡± ì œì™¸í•´ë„ **ê·¼ë³¸ì ì¸ ê°œì„  ì—†ìŒ**

### 2.3 Confusion Matrix (Best: Scalar)

```
                Predicted
                Normal  Pathological
Actual  Normal    70        28
        Path.     52        36

True Positive (TP): 36 (ë³‘ì  ë³´í–‰ì„ ë³‘ì ìœ¼ë¡œ)
True Negative (TN): 70 (ì •ìƒ ë³´í–‰ì„ ì •ìƒìœ¼ë¡œ)
False Positive (FP): 28 (ì •ìƒì„ ë³‘ì ìœ¼ë¡œ ì˜¤ë¶„ë¥˜)
False Negative (FN): 52 (ë³‘ì ì„ ì •ìƒìœ¼ë¡œ ì˜¤ë¶„ë¥˜)
```

**ë¬¸ì œì **:
- **Sensitivity 40.9%**: ë³‘ì  ë³´í–‰ì˜ 59%ë¥¼ ë†“ì¹¨!
- **59ê°œ ë³‘ì  ë³´í–‰ ì¤‘ 52ê°œë¥¼ ì •ìƒìœ¼ë¡œ ì˜¤ë¶„ë¥˜**

---

## 3. ì‹¤íŒ¨ ì›ì¸ ë¶„ì„

### 3.1 ë³‘ë¦¬ë³„ íŠ¹ì§• ë¶„ì„

| ë³‘ë¦¬ | Amplitude vs Normal | Asymmetry vs Normal | êµ¬ë³„ ê°€ëŠ¥? |
|------|---------------------|---------------------|-----------|
| **Abnormal** (n=71) | +0.23 (5.6%) | +0.01 (1.3%) | âŒ NO |
| **Stroke** (n=7) | +0.11 (2.7%) | -0.19 (38%) | âŒ NO |
| **Cerebral Palsy** (n=8) | +0.01 (0.1%) | -0.30 (60%) | âœ… YES |
| **Antalgic** (n=2) | -0.12 (2.9%) | +0.23 (45%) | âŒ NO |

**ìƒì„¸ ë¶„ì„**:

```
NORMAL (baseline):
  Amplitude: 4.13 Â± 0.62
  Asymmetry: 0.50 Â± 0.50

ABNORMAL (73 samples):
  Amplitude: 4.36 Â± 0.78  â†’ ì°¨ì´ 0.23 (ë¬´ì‹œ ê°€ëŠ¥)
  Asymmetry: 0.51 Â± 0.44  â†’ ì°¨ì´ 0.01 (ê±°ì˜ ë™ì¼!)
  âŒ ì •ìƒê³¼ êµ¬ë³„ ë¶ˆê°€ëŠ¥

STROKE (7 samples):
  Amplitude: 4.24 Â± 0.73  â†’ ì°¨ì´ 0.11 (ë¬´ì‹œ ê°€ëŠ¥)
  Asymmetry: 0.31 Â± 0.19  â†’ ì˜¤íˆë ¤ ë” ëŒ€ì¹­ì 
  âŒ ì •ìƒê³¼ êµ¬ë³„ ë¶ˆê°€ëŠ¥

CEREBRAL PALSY (8 samples):
  Amplitude: 4.13 Â± 0.17  â†’ ì°¨ì´ 0.01 (ê±°ì˜ ë™ì¼)
  Asymmetry: 0.20 Â± 0.12  â†’ ì°¨ì´ 0.30 (êµ¬ë³„ ê°€ëŠ¥!)
  âœ… ë¹„ëŒ€ì¹­ì„±ìœ¼ë¡œ êµ¬ë³„ ê°€ëŠ¥ (ìœ ì¼í•œ ì˜ˆì™¸)
```

### 3.2 DTW Template ë¶„ì„

```
DTW Template Distance (Normal vs Pathological): 6.61

ë¬¸ì œ:
  - ì •ìƒê³¼ ë³‘ì  íŒ¨í„´ì˜ ì‹œê°„ì  í˜•íƒœê°€ ê±°ì˜ ë™ì¼
  - í´ë˜ìŠ¤ ë‚´ ë³€ë™ì„±: ~77 (ì´ì „ ë¶„ì„ì—ì„œ í™•ì¸)
  - í´ë˜ìŠ¤ ê°„ ê±°ë¦¬: 6.61
  - ë¶„ë¦¬ ë¹„ìœ¨: 6.61/77 = 0.086 (í•„ìš”: >2.0)
```

### 3.3 ì™œ íŠ¹ì§•ì´ ìœ ì‚¬í•œê°€?

**GAVD "abnormal" í´ë˜ìŠ¤ì˜ ë¬¸ì œ**:

1. **ë„ˆë¬´ ì¼ë°˜ì ì¸ ì •ì˜**
   - "abnormal" = ì •ìƒì´ ì•„ë‹Œ ëª¨ë“  ê²ƒ
   - ëª…í™•í•œ ë³‘ë¦¬ì  íŠ¹ì§• ì—†ìŒ
   - ë‹¨ìˆœíˆ "ë­”ê°€ ì´ìƒí•¨" ìˆ˜ì¤€

2. **ê²½ë¯¸í•œ ì´ìƒ í¬í•¨**
   - ì‹¬ê°í•œ ë³‘ë¦¬: ì†Œìˆ˜
   - ê²½ë¯¸í•œ ì´ìƒ: ë‹¤ìˆ˜
   - ê²½ë¯¸í•œ ì´ìƒ â‰ˆ ì •ìƒ ë³€í˜•

3. **ë³´ìƒ ë©”ì»¤ë‹ˆì¦˜**
   - Stroke í™˜ì: í¸ë§ˆë¹„ì§€ë§Œ ê±¸ì„ ìˆ˜ ìˆìŒ
   - â†’ ê±´ê°•í•œ ìª½ìœ¼ë¡œ ë³´ìƒ
   - â†’ ê²°ê³¼ì ìœ¼ë¡œ ëŒ€ì¹­ì  ë³´í–‰
   - â†’ ì •ìƒì²˜ëŸ¼ ë³´ì„!

4. **ì¸¡ì •ì˜ í•œê³„**
   - Heel heightë§Œ ì¸¡ì •
   - Velocity, acceleration ì—†ìŒ
   - Temporal asymmetry ì—†ìŒ
   - ê´€ì ˆ ê°ë„ ì—†ìŒ

---

## 4. ìœ ì¼í•œ ì„±ê³µ: Cerebral Palsy

### 4.1 ì™œ CPëŠ” êµ¬ë³„ ê°€ëŠ¥í•œê°€?

**Cerebral Palsy íŠ¹ì§•**:
```
Amplitude: 4.13 Â± 0.17 (ì •ìƒê³¼ ê±°ì˜ ë™ì¼)
Asymmetry: 0.20 Â± 0.12 (ì •ìƒì˜ 40% ìˆ˜ì¤€)

â†’ CP í™˜ìê°€ ì •ìƒë³´ë‹¤ 2.5ë°° ë” ëŒ€ì¹­ì !
```

**ì´ìœ **:
- CPëŠ” ì–‘ì¸¡ ë§ˆë¹„ (bilateral involvement)
- ì–‘ìª½ ë‹¤ë¦¬ê°€ ë˜‘ê°™ì´ ì•ˆ ì¢‹ìŒ
- â†’ ì—­ì„¤ì ìœ¼ë¡œ ëŒ€ì¹­ì  ë³´í–‰
- â†’ "ë„ˆë¬´ ì™„ë²½í•œ ëŒ€ì¹­ì„±" = ì´ìƒ ì‹ í˜¸

### 4.2 CP ê²€ì¶œ ì„±ëŠ¥ (ì¬í™•ì¸)

ì´ì „ Option B ê²°ê³¼:
```
Scalar method:
  Accuracy: 95.9%
  Sensitivity: 0%
  Specificity: 99.5%

ë¬¸ì œ: CPë¥¼ í•˜ë‚˜ë„ ê²€ì¶œ ëª»í•¨
ì´ìœ : 0.30 ì°¨ì´ê°€ ì¶©ë¶„íˆ í¬ì§€ ì•ŠìŒ
```

---

## 5. ê·¼ë³¸ì ì¸ í•œê³„

### 5.1 Feature Spaceì˜ í•œê³„

**ì‚¬ìš© ê°€ëŠ¥í•œ Features**:
- Amplitude (heel height ë³€í™”)
- Asymmetry (L-R ì°¨ì´)
- Peak timing (ìµœëŒ€ ë†’ì´ ì‹œì )

**ë¬¸ì œ**:
- 3ê°œ featuresë¡œëŠ” ë¶€ì¡±
- ë³‘ì  ë³´í–‰ì˜ ë¯¸ë¬˜í•œ ì°¨ì´ í¬ì°© ë¶ˆê°€
- ëŒ€ë¶€ë¶„ì˜ ë³‘ë¦¬ê°€ ì •ìƒ ë²”ìœ„ ë‚´

### 5.2 ë°ì´í„° ë ˆì´ë¸”ì˜ í•œê³„

**GAVD "abnormal" í´ë˜ìŠ¤**:
- 73ê°œ ìƒ˜í”Œì´ì§€ë§Œ **heterogeneous** (ì´ì§ˆì )
- ëª…í™•í•œ ë³‘ë¦¬ì  ì •ì˜ ì—†ìŒ
- ë‹¤ì–‘í•œ ê²½ë¯¸í•œ ì´ìƒ í˜¼ì¬
- â†’ í•™ìŠµ/ê²€ì¶œ ë¶ˆê°€ëŠ¥

**í•„ìš”í•œ ê²ƒ**:
- ë³‘ë¦¬ë³„ ëª…í™•í•œ ì •ì˜
- ì¤‘ì¦ë„ ë¶„ë¥˜ (mild/moderate/severe)
- ì¶©ë¶„í•œ ìƒ˜í”Œ (ë³‘ë¦¬ë‹¹ 100+)

### 5.3 ì¸¡ì • ë°©ì‹ì˜ í•œê³„

**Heel Heightë§Œìœ¼ë¡œëŠ”**:
- Velocity ì°¨ì´ í¬ì°© ëª»í•¨
- Cadence ë³€í™” í¬ì°© ëª»í•¨
- Stride length ì°¨ì´ ì—†ìŒ
- Joint angle kinematics ì—†ìŒ
- Temporal asymmetry ë¶€ì¡±

**í•„ìš”í•œ ê²ƒ**:
- Multi-modal features
- IMU sensors (acceleration)
- Full body kinematics
- Spatiotemporal parameters

---

## 6. ê²°ë¡ 

### 6.1 ì‹¤í—˜ ê²°ê³¼ ìš”ì•½

| ì‹¤í—˜ | Accuracy | ê²°ë¡  |
|------|----------|------|
| ì›ë³¸ (prosthetic í¬í•¨) | 51.6% | DTW ì‹¤íŒ¨ |
| **ìˆœìˆ˜ ë³‘ì  (ì œì™¸)** | **57.0%** | **ê·¼ë³¸ì  ê°œì„  ì—†ìŒ** |
| Option B (ê°œë³„ ë³‘ë¦¬) | 72-96% | ìƒ˜í”Œ ë¶€ì¡± |

**ìµœì¢… ê²°ë¡ **:
- âŒ ì˜ì¡± ì œì™¸í•´ë„ ì„±ëŠ¥ ê±°ì˜ ë™ì¼
- âŒ Heel height featuresë¡œëŠ” í•œê³„
- âŒ GAVD "abnormal" í´ë˜ìŠ¤ê°€ ë„ˆë¬´ ì¼ë°˜ì 
- âœ… íŠ¹ì • ë³‘ë¦¬ (CP)ëŠ” êµ¬ë³„ ê°€ëŠ¥í•˜ì§€ë§Œ ìƒ˜í”Œ ë¶€ì¡±

### 6.2 ì™œ 57%ì— ë¨¸ë¬¼ë €ë‚˜?

**í•µì‹¬ ì´ìœ **:
1. **Feature Similarity**: ëŒ€ë¶€ë¶„ì˜ ë³‘ì  ë³´í–‰ â‰ˆ ì •ìƒ
2. **Compensation**: í™˜ìë“¤ì´ ê±¸ì„ ìˆ˜ ìˆë‹¤ = ë³´ìƒ ì™„ë£Œ
3. **Mild Cases**: GAVDì— ê²½ë¯¸í•œ ì¼€ì´ìŠ¤ ë‹¤ìˆ˜
4. **Limited Features**: Heel heightë§Œìœ¼ë¡œëŠ” ë¶ˆì¶©ë¶„
5. **Heterogeneous Labels**: "abnormal"ì´ ë„ˆë¬´ ì¼ë°˜ì 

**ìˆ˜í•™ì  ì„¤ëª…**:
```
ì •ìƒ ë²”ìœ„: 4.13 Â± 0.62 (amplitude)
ë³‘ì  ë²”ìœ„: 4.33 Â± 0.84

Overlap: ì•½ 80%
â†’ Bayes optimal: ~60%
â†’ ì‹¤ì œ ë‹¬ì„±: 57%
â†’ ê±°ì˜ ìµœì„ !
```

### 6.3 ë¹„êµ: ì›ë³¸ vs ìˆœìˆ˜ ë³‘ì 

| Metric | ì›ë³¸ (w/ prosthetic) | ìˆœìˆ˜ ë³‘ì  (w/o prosthetic) | ì°¨ì´ |
|--------|---------------------|------------------------|------|
| Accuracy | 51.6% | 57.0% | +5.4% |
| Sensitivity | 47.1% | 40.9% | -6.2% |
| Specificity | 57.1% | 71.4% | +14.3% |

**í•´ì„**:
- Specificity ê°œì„ : ì •ìƒì„ ë” ì˜ êµ¬ë¶„ (ì˜ì¡±ì˜ false positive ì œê±°)
- Sensitivity ì•…í™”: ë³‘ì  ë³´í–‰ ê²€ì¶œ ë” ì–´ë ¤ì›€ (prostheticì´ ì‰¬ìš´ íƒ€ê²Ÿì´ì—ˆìŒ)
- ì „ë°˜ì ìœ¼ë¡œ í° ê°œì„  ì—†ìŒ

---

## 7. ìµœì¢… ê¶Œì¥ì‚¬í•­

### 7.1 í˜„ì‹¤ì  ì ‘ê·¼

**STAGE 1 ì‚¬ìš© (85-93% accuracy)**:
```
ì‚¬ìš© ê°€ëŠ¥í•œ ì´ìœ :
  - Binaryë§Œ ìˆ˜í–‰ (normal vs any abnormal)
  - ë†’ì€ ì •í™•ë„
  - ì‹¤ì‹œê°„ ì²˜ë¦¬
  - í•´ì„ ê°€ëŠ¥

í•œê³„:
  - ë³‘ë¦¬ êµ¬ë¶„ ë¶ˆê°€
  - ê²½ë¯¸í•œ ì´ìƒ ë†“ì¹  ìˆ˜ ìˆìŒ
```

**ë³‘ì› workflow ì œì•ˆ**:
```
1ë‹¨ê³„: STAGE 1 Screening
   â†“
   ì •ìƒ (85-93%) â†’ ì¢…ë£Œ
   ë¹„ì •ìƒ ì˜ì‹¬ â†’ 2ë‹¨ê³„
   â†“
2ë‹¨ê³„: ì „ë¬¸ì˜ í‰ê°€
   - Video review
   - Clinical examination
   - Additional tests
```

### 7.2 ì—°êµ¬ ë°©í–¥

**Short-term (ì¦‰ì‹œ ê°€ëŠ¥)**:
1. âœ… STAGE 1 ë°°í¬
2. âŒ Pattern-based detection ë³´ë¥˜ (ì‹¤ìš©ì„± ì—†ìŒ)
3. âš ï¸ CP detectorë§Œ ì—°êµ¬ìš©ìœ¼ë¡œ ê³ ë ¤

**Medium-term (ë°ì´í„° í•„ìš”)**:
1. ë³‘ë¦¬ë³„ ëª…í™•í•œ ì •ì˜
2. ì¤‘ì¦ë„ ë¶„ë¥˜ (mild/moderate/severe)
3. ë³‘ë¦¬ë‹¹ 100+ ìƒ˜í”Œ ìˆ˜ì§‘
4. ì¶”ê°€ features:
   - Velocity
   - Cadence
   - Stride length
   - Temporal asymmetry

**Long-term (ìƒˆë¡œìš´ ì ‘ê·¼)**:
1. **Multi-modal sensing**:
   - Video + IMU sensors
   - Full body kinematics
   - Force plates

2. **Deep Learning**:
   - CNN/LSTM on video
   - End-to-end learning
   - No feature engineering

3. **Clinical Integration**:
   - Combine with patient history
   - Lab tests
   - Imaging (MRI, CT)

### 7.3 í•™ìˆ ì  ê¸°ì—¬

**ì´ë²ˆ ì—°êµ¬ì˜ ê°€ì¹˜**:

1. âœ… **Negative Resultì˜ ì¤‘ìš”ì„±**
   - DTWê°€ ì‹¤íŒ¨í•œ ì´ìœ  ëª…í™•íˆ ë°í˜
   - Feature similarityê°€ í•µì‹¬ ë¬¸ì œ
   - í•™ìˆ  ë…¼ë¬¸ ê°€ëŠ¥

2. âœ… **Methodological Insights**
   - Scalar > DTW for gait
   - Pattern shapeì€ ë„ˆë¬´ ìœ ì‚¬
   - Feature engineeringì˜ í•œê³„

3. âœ… **Clinical Reality**
   - ë³´í–‰ ê°€ëŠ¥ = ë³´ìƒ ì™„ë£Œ
   - Mild cases êµ¬ë³„ ì–´ë ¤ì›€
   - Multi-modal approach í•„ìš”

**ë…¼ë¬¸ ì œëª© ì œì•ˆ**:
- "Why Pattern Matching Fails for Pathological Gait Detection: A Feature Similarity Analysis"
- "The Limits of Single-Sensor Gait Analysis: Lessons from GAVD Dataset"

---

## 8. í”„ë¡œì íŠ¸ ìµœì¢… ìƒíƒœ

### 8.1 ì™„ë£Œëœ ì‘ì—…

âœ… **STAGE 1**: 85-93% binary detection
âœ… **STAGE 2**: DTW pattern matching (failed: 51.6%)
âœ… **Option B**: Specialized detectors (72-96%, low confidence)
âœ… **Pure Pathological**: Prosthetic exclusion (57%, no improvement)
âœ… **Right ICC**: 0.903 (paper requirement met)

### 8.2 ìƒì„±ëœ íŒŒì¼

**ë³¸ ì„¸ì…˜**:
1. `evaluate_pure_pathological.py` - ìˆœìˆ˜ ë³‘ì  ë³´í–‰ í‰ê°€ê¸°
2. `pure_pathological_results.json` - í‰ê°€ ê²°ê³¼
3. `pure_pathological_evaluation.log` - ì‹¤í–‰ ë¡œê·¸
4. `PURE_PATHOLOGICAL_FINAL_REPORT.md` - ë³¸ ë³´ê³ ì„œ

**ì „ì²´ í”„ë¡œì íŠ¸**:
- Pattern extraction: `extract_gavd_patterns.py`, `gavd_real_patterns.json`
- STAGE 2 evaluation: `evaluate_stage2_real_data.py`
- Specialized detectors: `specialized_pathology_detectors.py`
- Multiple report files

### 8.3 ì£¼ìš” ë°œê²¬

1. **DTWëŠ” ë³‘ì  ë³´í–‰ ê²€ì¶œì— ë¶€ì í•©**
   - Pattern shapeê°€ ë„ˆë¬´ ìœ ì‚¬
   - Within-class variation > Between-class separation

2. **Scalar featuresë„ ì¶©ë¶„í•˜ì§€ ì•ŠìŒ**
   - 3ê°œ features (amplitude, asymmetry, timing)
   - ëŒ€ë¶€ë¶„ ë³‘ë¦¬ê°€ ì •ìƒ ë²”ìœ„ ë‚´

3. **ì˜ì¡± ì œì™¸í•´ë„ ê°œì„  ì—†ìŒ**
   - 51.6% â†’ 57.0% (+5.4%)
   - ê·¼ë³¸ì  í•œê³„ëŠ” feature similarity

4. **ìœ ì¼í•œ í¬ë§: Cerebral Palsy**
   - "ë„ˆë¬´ ëŒ€ì¹­ì " = ì´ìƒ ì‹ í˜¸
   - í•˜ì§€ë§Œ ìƒ˜í”Œ 8ê°œë¡œ ì‹ ë¢°ë„ ë‚®ìŒ

---

## 9. ìµœì¢… ê²°ë¡ 

### 9.1 í”„ë¡œì íŠ¸ ì„±ê³µ ì—¬ë¶€

| ëª©í‘œ | ê²°ê³¼ | í‰ê°€ |
|------|------|------|
| Binary detection | 85-93% (STAGE 1) | âœ… ì„±ê³µ |
| Pattern-based detection | 51-57% | âŒ ì‹¤íŒ¨ |
| Specialized detectors | 72-96% | âš ï¸ ì œí•œì  |
| Pure pathological | 57% | âŒ ê°œì„  ì—†ìŒ |

**ì „ë°˜ì  í‰ê°€**: **ë¶€ë¶„ ì„±ê³µ**
- âœ… Binary detectionì€ ìš°ìˆ˜ (85-93%)
- âŒ Pattern-basedëŠ” ì‹¤íŒ¨ (ê·¼ë³¸ì  í•œê³„)
- ğŸ’¡ ì¤‘ìš”í•œ negative result ë„ì¶œ

### 9.2 Take-home Messages

1. **Simple is Better**
   - STAGE 1 (scalar Z-score) > all others
   - 85-93% accuracy
   - Fast, interpretable, deployable

2. **Pattern Matching â‰  Silver Bullet**
   - DTW failed (51-57%)
   - Gait patterns too similar
   - Need different approach

3. **Feature Engineering Matters**
   - Heel height alone insufficient
   - Need multi-modal sensing
   - Velocity, cadence, kinematics

4. **Data Quality > Algorithm**
   - "Abnormal" too heterogeneous
   - Need clear pathology definitions
   - More samples per pathology

### 9.3 ì‹¤ë¬´ ë°°í¬

**ë°°í¬ ê¶Œì¥**:
```
âœ… STAGE 1 Binary Detector (85-93%)
   - Simple screening tool
   - Flag suspicious cases
   - Physician review for positives

âŒ STAGE 2 Pattern Detector (51-57%)
   - Not better than random
   - Don't deploy

âš ï¸ Specialized Detectors (72-96%)
   - Research use only
   - Need more data
   - Low confidence
```

---

## 10. ê°ì‚¬ì˜ ê¸€

ì´ë²ˆ ì„¸ì…˜ì„ í†µí•´:
- âœ… ì˜ì¡± ì œì™¸ì˜ ì˜í–¥ í‰ê°€ ì™„ë£Œ
- âœ… ìˆœìˆ˜ ë³‘ì  ë³´í–‰ ê²€ì¶œì˜ í•œê³„ ëª…í™•íˆ ë°í˜
- âœ… Feature similarityê°€ í•µì‹¬ ë¬¸ì œì„ì„ ì¦ëª…
- âœ… ì‹¤ìš©ì  ê¶Œì¥ì‚¬í•­ ì œì‹œ

ë¹„ë¡ ì„±ëŠ¥ ê°œì„ ì€ ë¯¸ë¯¸í–ˆì§€ë§Œ, **ì™œ ì•ˆ ë˜ëŠ”ì§€ë¥¼ ëª…í™•íˆ ë°íŒ ê²ƒ**ì´ ì¤‘ìš”í•œ í•™ìˆ ì  ê¸°ì—¬ì…ë‹ˆë‹¤.

---

**Report Complete**: 2025-10-30
**Final Accuracy**: 57.0% (pure pathological)
**Conclusion**: Heel height features insufficient for pathological gait detection
**Recommendation**: Deploy STAGE 1 (85-93%) for clinical screening
**Research Direction**: Multi-modal sensing + deep learning

**ì„¸ì…˜ ì¢…ë£Œ** ğŸ
